Revenue Summary of ResMed Inc.

ResMed Inc.'s latest annual revenue in 2024 was 4.68 Billion USD , up 10.95% from previous year.
ResMed Inc.'s latest quarterly revenue in 2024 FY was 4.68 Billion USD , up 10.95% from previous quarter.
ResMed Inc. reported a annual revenue of 4.22 Billion USD in annual revenue 2023, up 18.02% from previous year.
ResMed Inc. reported a annual revenue of 3.57 Billion USD in annual revenue 2022, up 11.93% from previous year.
ResMed Inc. reported a quarterly revenue of 1.22 Billion USD for 2024 Q4, up 2.19% from previous quarter.
ResMed Inc. reported a quarterly revenue of 4.68 Billion USD for 2024 FY, up 10.95% from previous quarter.

Annual Revenue Chart of ResMed Inc. (2024 - 1993)

Historical Annual Revenue of ResMed Inc. (2024 - 1993)

Year	Revenue	Revenue Growth
2024	4.68 Billion USD	10.95%
2023	4.22 Billion USD	18.02%
2022	3.57 Billion USD	11.93%
2021	3.19 Billion USD	8.11%
2020	2.95 Billion USD	13.44%
2019	2.6 Billion USD	11.38%
2018	2.34 Billion USD	13.23%
2017	2.06 Billion USD	12.4%
2016	1.83 Billion USD	9.52%
2015	1.67 Billion USD	7.97%
2014	1.55 Billion USD	2.68%
2013	1.51 Billion USD	10.66%
2012	1.36 Billion USD	10.08%
2011	1.24 Billion USD	13.8%
2010	1.09 Billion USD	18.64%
2009	920.73 Million USD	10.22%
2008	835.39 Million USD	16.62%
2007	716.33 Million USD	18.01%
2006	606.99 Million USD	42.65%
2005	425.5 Million USD	25.39%
2004	339.33 Million USD	24.04%
2003	273.57 Million USD	34.05%
2002	204.07 Million USD	31.53%
2001	155.15 Million USD	34.2%
2000	115.61 Million USD	30.49%
1999	88.6 Million USD	33.23%
1998	66.5 Million USD	35.16%
1997	49.2 Million USD	42.2%
1996	34.6 Million USD	47.23%
1995	23.5 Million USD	69.06%
1994	13.9 Million USD	80.52%
1993	7.7 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	1.16 Billion USD	20.74%
2024 Q4	1.22 Billion USD	2.19%
2024 FY	4.68 Billion USD	10.95%
2024 Q3	1.19 Billion USD	2.94%
2024 Q1	963.03 Million USD	-14.17%
2023 FY	4.22 Billion USD	18.02%
2023 Q3	1.11 Billion USD	8.04%
2023 Q4	1.12 Billion USD	0.46%
2023 Q2	1.03 Billion USD	8.78%
2023 Q1	950.29 Million USD	3.89%
2022 Q1	904.01 Million USD	3.19%
2022 Q3	864.5 Million USD	-3.39%
2022 FY	3.57 Billion USD	11.93%
2022 Q4	914.73 Million USD	5.81%
2022 Q2	894.87 Million USD	-1.01%
2021 FY	3.19 Billion USD	8.11%
2021 Q4	876.1 Million USD	13.96%
2021 Q2	800.01 Million USD	6.39%
2021 Q1	751.94 Million USD	-2.39%
2021 Q3	768.76 Million USD	-3.91%
2020 Q3	769.45 Million USD	4.52%
2020 FY	2.95 Billion USD	13.44%
2020 Q4	770.34 Million USD	0.12%
2020 Q1	681.05 Million USD	-3.39%
2020 Q2	736.15 Million USD	8.09%
2019 Q2	651.1 Million USD	10.68%
2019 FY	2.6 Billion USD	11.38%
2019 Q4	704.96 Million USD	6.45%
2019 Q1	588.27 Million USD	-5.67%
2019 Q3	662.22 Million USD	1.71%
2018 Q4	623.63 Million USD	5.41%
2018 FY	2.34 Billion USD	13.23%
2018 Q3	591.63 Million USD	-1.6%
2018 Q2	601.27 Million USD	14.82%
2018 Q1	523.65 Million USD	-5.93%
2017 Q2	530.39 Million USD	13.95%
2017 Q3	514.2 Million USD	-3.05%
2017 FY	2.06 Billion USD	12.4%
2017 Q4	556.68 Million USD	8.26%
2017 Q1	465.45 Million USD	-10.26%
2016 Q2	454.54 Million USD	10.42%
2016 FY	1.83 Billion USD	9.52%
2016 Q3	453.87 Million USD	-0.15%
2016 Q4	518.64 Million USD	14.27%
2016 Q1	411.64 Million USD	-9.14%
2015 Q4	453.06 Million USD	7.23%
2015 Q3	422.49 Million USD	-0.11%
2015 Q1	380.39 Million USD	-8.38%
2015 FY	1.67 Billion USD	7.97%
2015 Q2	422.95 Million USD	11.19%
2014 FY	1.55 Billion USD	2.68%
2014 Q4	415.21 Million USD	4.39%
2014 Q1	357.66 Million USD	-13.73%
2014 Q2	384.34 Million USD	7.46%
2014 Q3	397.75 Million USD	3.49%
2013 FY	1.51 Billion USD	10.66%
2013 Q1	339.73 Million USD	-8.66%
2013 Q2	376.53 Million USD	10.83%
2013 Q4	414.6 Million USD	8.09%
2013 Q3	383.58 Million USD	1.87%
2012 Q3	349.07 Million USD	4.91%
2012 FY	1.36 Billion USD	10.08%
2012 Q1	314.77 Million USD	-7.93%
2012 Q2	332.73 Million USD	5.71%
2012 Q4	371.92 Million USD	6.55%
2011 Q2	305.98 Million USD	8.5%
2011 Q3	901.25 Million USD	194.54%
2011 Q4	341.89 Million USD	-62.06%
2011 FY	1.24 Billion USD	13.8%
2011 Q1	282.01 Million USD	-3.28%
2010 FY	1.09 Billion USD	18.64%
2010 Q1	246.99 Million USD	-1.97%
2010 Q2	275.13 Million USD	11.39%
2010 Q3	278.65 Million USD	1.28%
2010 Q4	291.57 Million USD	4.63%
2009 Q3	227.86 Million USD	2.19%
2009 Q2	222.98 Million USD	2.32%
2009 Q4	251.95 Million USD	10.57%
2009 Q1	217.93 Million USD	-7.32%
2009 FY	920.73 Million USD	10.22%
2008 Q1	185.74 Million USD	-2.91%
2008 FY	835.39 Million USD	16.62%
2008 Q4	235.15 Million USD	11.01%
2008 Q3	211.82 Million USD	4.51%
2008 Q2	202.67 Million USD	9.12%
2007 Q1	163.6 Million USD	-4.42%
2007 Q2	178.42 Million USD	9.06%
2007 FY	716.33 Million USD	18.01%
2007 Q4	191.3 Million USD	4.55%
2007 Q3	182.99 Million USD	2.56%
2006 Q3	162.28 Million USD	10.83%
2006 Q4	171.17 Million USD	5.48%
2006 Q2	146.41 Million USD	15.17%
2006 Q1	127.12 Million USD	1.36%
2006 FY	606.99 Million USD	42.65%
2005 Q2	103.89 Million USD	18.42%
2005 Q1	87.73 Million USD	-5.55%
2005 FY	425.5 Million USD	25.39%
2005 Q4	125.42 Million USD	15.65%
2005 Q3	108.45 Million USD	4.39%
2004 Q1	72.87 Million USD	-9.69%
2004 Q2	82.29 Million USD	12.92%
2004 FY	339.33 Million USD	24.04%
2004 Q4	92.89 Million USD	1.77%
2004 Q3	91.27 Million USD	10.92%
2003 Q2	65.29 Million USD	11.45%
2003 Q3	68.99 Million USD	5.67%
2003 Q4	80.69 Million USD	16.96%
2003 FY	273.57 Million USD	34.05%
2003 Q1	58.58 Million USD	4.16%
2002 FY	204.07 Million USD	31.53%
2002 Q3	52.77 Million USD	7.87%
2002 Q1	46.12 Million USD	-1.91%
2002 Q2	48.92 Million USD	6.06%
2002 Q4	56.24 Million USD	6.58%
2001 Q4	47.02 Million USD	10.19%
2001 FY	155.15 Million USD	34.2%
2001 Q3	42.68 Million USD	24.19%
2001 Q2	34.36 Million USD	10.57%
2001 Q1	31.08 Million USD	-1.53%
2000 Q2	28.1 Million USD	8.49%
2000 Q3	29.97 Million USD	6.66%
2000 Q4	31.56 Million USD	5.32%
2000 FY	115.61 Million USD	30.49%
2000 Q1	25.9 Million USD	3.19%
1999 Q1	19.2 Million USD	-0.52%
1999 Q2	21.5 Million USD	11.98%
1999 Q3	22.8 Million USD	6.05%
1999 Q4	25.1 Million USD	10.09%
1999 FY	88.6 Million USD	33.23%
1998 Q1	14 Million USD	0.0%
1998 Q3	17.1 Million USD	6.21%
1998 Q4	19.3 Million USD	12.87%
1998 FY	66.5 Million USD	35.16%
1998 Q2	16.1 Million USD	15.0%
1997 FY	49.2 Million USD	42.2%
1997 Q3	12.5 Million USD	7.76%
1997 Q4	14 Million USD	12.0%
1997 Q1	11.1 Million USD	4.72%
1997 Q2	11.6 Million USD	4.5%
1996 FY	34.6 Million USD	47.23%
1996 Q3	9.4 Million USD	18.99%
1996 Q4	10.6 Million USD	12.77%
1996 Q1	6.7 Million USD	0.0%
1996 Q2	7.9 Million USD	17.91%
1995 Q2	5.6 Million USD	0.0%
1995 Q3	5.6 Million USD	0.0%
1995 FY	23.5 Million USD	69.06%
1995 Q4	6.7 Million USD	19.64%
1995 Q1	5.6 Million USD	64.71%
1994 Q4	3.4 Million USD	-2.86%
1994 FY	13.9 Million USD	80.52%
1994 Q1	3.5 Million USD	75.0%
1994 Q3	3.5 Million USD	0.0%
1994 Q2	3.5 Million USD	0.0%
1993 Q2	1.9 Million USD	0.0%
1993 FY	7.7 Million USD	0.0%
1993 Q3	1.9 Million USD	0.0%
1993 Q1	1.9 Million USD	0.0%
1993 Q4	2 Million USD	5.26%

Peer Revenue Comparison of ResMed Inc.

Name	Revenue	Revenue Difference
Alcon Inc.	10.09 Billion USD	53.574%
AptarGroup, Inc.	3.48 Billion USD	-34.347%
Baxter International Inc.	14.81 Billion USD	68.37%
Becton, Dickinson and Company	20.17 Billion USD	76.78%
Bausch + Lomb Corporation	4.14 Billion USD	-13.008%
Haemonetics Corporation	1.3 Billion USD	-257.914%
Envista Holdings Corp	2.56 Billion USD	-82.556%
Teleflex Incorporated	2.97 Billion USD	-57.516%
Warby Parker Inc.	669.76 Million USD	-599.543%
West Pharmaceutical Services, Inc.	2.94 Billion USD	-58.834%

Global Stocks Search

ResMed Inc. (RMD)

Revenue Summary of ResMed Inc.

Annual Revenue Chart of ResMed Inc. (2024 - 1993)

Historical Annual Revenue of ResMed Inc. (2024 - 1993)

Peer Revenue Comparison of ResMed Inc.